PMID: 3753129Sep 1, 1986Paper

Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate

Archives of Internal Medicine
J M HughesM O Thorner

Abstract

We present, to our knowledge, the first case of Cushing's syndrome due to large doses of intramuscular dexamethasone acetate. Dexamethasone levels after intramuscular dexamethasone administration were measured in two patients. Serial determination of the dexamethasone levels demonstrated prolonged serum half-lives of seven and 33 days in the two patients, respectively. Furthermore, pharmacologic levels of dexamethasone were present as long as seven months after the initial injections. The present recommendation for the use of intramuscular dexamethasone acetate is as frequent as every one to three weeks. However, our patients demonstrate that supraphysiologic levels of dexamethasone may still be present well beyond the three-week period.

Citations

Jun 6, 2008·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Everardo Alvarez-HernándezRubén Burgos-Vargas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Related Papers

The Turkish Journal of Pediatrics
Ibrahim Ilker CetinKürşad Tokel
Scottish Medical Journal
A J McMahonW S Hillis
© 2021 Meta ULC. All rights reserved